13D/13G Filings - Blue Owl Capital Holdings LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-06
8:55 pm
Purchase
2025-09-2913DKatapult Holdings, Inc.
KPLT
Blue Owl Capital Holdings LP2,603,447
36.320%
1,935,762increase
(+289.92%)
Filing
History
2025-09-05
4:00 pm
Purchase
2025-08-3113GKatapult Holdings, Inc.
KPLT
Blue Owl Capital Holdings LP667,685
12.760%
667,685increase
(New Position)
Filing
History
2025-08-11
5:57 pm
Purchase
2025-06-3013GBiomea Fusion, Inc.
BMEA
Blue Owl Capital Holdings LP3,800,000
6.130%
3,800,000increase
(New Position)
Filing
History
2025-05-15
4:13 pm
Purchase
2025-03-3113GMarker Therapeutics, Inc.
MRKR
Blue Owl Capital Holdings LP1,127,052
9.990%
572,802increase
(+103.35%)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-3113GSagimet Biosciences Inc.
SGMT
Blue Owl Capital Holdings LP1,323,877
4.320%
-350,000decrease
(-20.91%)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-3113GContext Therapeutics Inc.
CNTX
Blue Owl Capital Holdings LP6,357,928
8.480%
946,638increase
(+17.49%)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-3113GAEON Biopharma, Inc.
AEON
Blue Owl Capital Holdings LP42,352
3.810%
-4,053decrease
(-8.73%)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-3113GTourmaline Bio, Inc.
TRML
Blue Owl Capital Holdings LP1,079,321
4.200%
-451,080decrease
(-29.47%)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-3113GMarker Therapeutics, Inc.
MRKR
Blue Owl Capital Holdings LP554,250
5.180%
554,250increase
(New Position)
Filing
History
2025-02-14
5:09 pm
Sale
2024-12-3113GGeneration Asia I Acquisition Limited
GAQ
Blue Owl Capital Holdings LP0
0.000%
-573,000decrease
(Position Closed)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-3113GFS Credit Opportunities Corp.
FSCO
Blue Owl Capital Holdings LP50,000
16.670%
50,000increase
(New Position)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-3113GLUMENT FIN TR INC RED
LFTPRA
Blue Owl Capital Holdings LP200,000
8.330%
200,000increase
(New Position)
Filing
History
2025-02-14
5:09 pm
Purchase
2024-12-3113GARBOR RLTY TR INC
ABRPRE
Blue Owl Capital Holdings LP360,000
6.260%
360,000increase
(New Position)
Filing
History
2024-11-14
5:05 pm
Sale
2024-09-3013GSyros Pharmaceuticals, Inc.
SYRS
Blue Owl Capital Holdings LP515,855
1.920%
-977,397decrease
(-65.45%)
Filing
History
2024-11-14
5:05 pm
Unchanged
2024-09-3013GPliant Therapeutics, Inc.
PLRX
Blue Owl Capital Holdings LP3,004,199
4.940%
0
(Unchanged)
Filing
History
2024-11-14
5:05 pm
Sale
2024-09-3013GCullinan Therapeutics, Inc.
CGEM
Blue Owl Capital Holdings LP2,010,972
3.450%
-1,408,870decrease
(-41.20%)
Filing
History
2024-11-14
5:05 pm
Sale
2024-09-3013GOrchard Therapeutics plc
ORTX
Blue Owl Capital Holdings LP0
0.000%
-15,596,600decrease
(Position Closed)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-3013GenGene Holdings Inc.
ENGN
Blue Owl Capital Holdings LP3,095,069
7.000%
1,860,309increase
(+150.66%)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-3013GTourmaline Bio, Inc.
TRML
Blue Owl Capital Holdings LP1,530,401
6.000%
198,099increase
(+14.87%)
Filing
History
2024-11-14
5:05 pm
Purchase
2024-09-3013GLarimar Therapeutics, Inc.
LRMR
Blue Owl Capital Holdings LP4,166,829
6.530%
752,361increase
(+22.03%)
Filing
History
Goto 0, 1, Next